Hind T. Hatoum

2.6k total citations
72 papers, 2.0k citations indexed

About

Hind T. Hatoum is a scholar working on Geriatrics and Gerontology, Economics and Econometrics and General Health Professions. According to data from OpenAlex, Hind T. Hatoum has authored 72 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Geriatrics and Gerontology, 12 papers in Economics and Econometrics and 11 papers in General Health Professions. Recurrent topics in Hind T. Hatoum's work include Pharmaceutical Practices and Patient Outcomes (18 papers), Health Systems, Economic Evaluations, Quality of Life (11 papers) and Pharmaceutical studies and practices (7 papers). Hind T. Hatoum is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (18 papers), Health Systems, Economic Evaluations, Quality of Life (11 papers) and Pharmaceutical studies and practices (7 papers). Hind T. Hatoum collaborates with scholars based in United States, Switzerland and United Kingdom. Hind T. Hatoum's co-authors include Sheldon X. Kong, Susan Keller, Swu‐Jane Lin, Richard A. Hutchinson, Mark Kosinski, Kasem S. Akhras, Roy D. Altman, John E. Ware, Josephine Wong and Wallace B. Mendelson and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Hind T. Hatoum

71 papers receiving 1.9k citations

Peers

Countries citing papers authored by Hind T. Hatoum

Since Specialization

Citations

This map shows the geographic impact of Hind T. Hatoum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hind T. Hatoum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hind T. Hatoum more than expected).

Fields of papers citing papers by Hind T. Hatoum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hind T. Hatoum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hind T. Hatoum. The network helps show where Hind T. Hatoum may publish in the future.

Co-authorship network of co-authors of Hind T. Hatoum

This figure shows the co-authorship network connecting the top 25 collaborators of Hind T. Hatoum. A scholar is included among the top collaborators of Hind T. Hatoum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hind T. Hatoum. Hind T. Hatoum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real‐world antiseizure medication treatment outcomes in drug‐resistant focal epilepsy patients 2023 ·Epilepsia Open ·Hind T. Hatoum, Steve Arcona, (unknown), Surrey M. Walton	2
2	The relationship between patients’ knowledge of diabetes therapeutic goals and self-management behaviour, including adherence 2016 ·International Journal of Clinical Pharmacy ·Mohammad Waheedi, Abdelmoneim Awad, Hind T. Hatoum, Hannes Enlund	17
3	Achieving Serum Urate Goal: A Comparative Effectiveness Study between Allopurinol and Febuxostat 2014 ·Postgraduate Medicine ·Hind T. Hatoum, Dinesh Khanna, Swu‐Jane Lin, Kasem S. Akhras, Aki Shiozawa, Puja Khanna	20
4	Cost-effectiveness analysis of intra-articular injections of a high molecular weight bioengineered hyaluronic acid for the treatment of osteoarthritis knee pain 2014 ·Journal of Medical Economics ·Hind T. Hatoum, Anke Fierlinger, Swu‐Jane Lin, Roy D. Altman	34
5	Impact of 5-HT3 receptor antagonists on chemotherapy-induced nausea and vomiting: a retrospective cohort study 2012 ·BMC Health Services Research ·Swu‐Jane Lin, Hind T. Hatoum, Deborah Buchner, David L. Cox, Sanjeev Balu	16
6	Outcomes and management costs in patients hospitalized for skin and skin-structure infections 2010 ·American Journal of Infection Control ·Kamal M.F. Itani, Sanjay Merchant, Swu‐Jane Lin, Kasem S. Akhras, (unknown), Hind T. Hatoum	41
7	The attributable clinical and economic burden of skin and skin structure infections in hospitalized patients: a matched cohort study 2009 ·Diagnostic Microbiology and Infectious Disease ·Hind T. Hatoum, Kasem S. Akhras, Swu‐Jane Lin	42
8	Predicting time to nursing home placement based on activities of daily living scores – a modelling analysis using data on Alzheimer's disease patients receiving rivastigmine or donepezil 2009 ·Journal of Medical Economics ·Hind T. Hatoum, Simu K. Thomas, (unknown), Roger Lane, Roger Bullock	35
9	Zoledronic acid and skeletal complications in patients with solid tumors and bone metastases 2008 ·Cancer ·Hind T. Hatoum, Swu‐Jane Lin, Matthew Ryan Smith, Victoria Barghout, Allan Lipton	89
10	The Use of the Occupational Disruptiveness Scale of the Neuropsychiatric Inventory-Nursing Home Version to Measure the Impact of Rivastigmine on the Disruptive Behavior of Nursing Home Residents With Alzheimer’s Disease 2005 ·Journal of the American Medical Directors Association ·Hind T. Hatoum, Swu‐Jane Lin, Stephen Arcona, Simu K. Thomas, Barbara Koumaras, Dario Mirski	13
11	A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data 2005 ·Fertility and Sterility ·Hind T. Hatoum, William R. Keye, Richard P. Marrs, Surrey M. Walton, Dennis C. Marshall	11
12	The SF-36 Health Survey as a Generic Outcome Measure in Clinical Trials of Patients With Osteoarthritis and Rheumatoid Arthritis 1999 ·Medical Care ·Mark Kosinski, Susan Keller, Hind T. Hatoum, Sheldon X. Kong, John E. Ware	160
13	The SF-36 Arthritis-Specific Health Index (ASHI) 1999 ·Medical Care ·Susan Keller, John E. Ware, Hind T. Hatoum, Sheldon X. Kong	37
14	The SF-36 Arthritis-Specific Health Index (ASHI) 1999 ·Medical Care ·John E. Ware, Susan Keller, Hind T. Hatoum, Sheldon X. Kong	54
15	Prevalence of insomnia: a survey of the enrollees at five managed care organizations. 1998 ·PubMed ·Hind T. Hatoum, (unknown), Sheldon X. Kong, Josephine Wong, Wallace B. Mendelson	52
16	A comparative profile of clinical pharmacy activities for pharmacotherapists and residents in a university hospital. 1996 ·PubMed ·(unknown), Hind T. Hatoum, (unknown), (unknown)	2
17	The use of pharmacoeconomic data in formulary selection. 1994 ·PubMed ·Hind T. Hatoum, (unknown)	8
18	OBRA 90: Patient counseling - Enhancing patient outcomes 1993 ·Hind T. Hatoum, Richard A. Hutchinson, Bruce L. Lambert	6
19	Physicians' Review of Significant Interventions by Clinical Pharmacists in Inpatient Care 1988 ·Drug Intelligence & Clinical Pharmacy ·Hind T. Hatoum, Richard A. Hutchinson, (unknown), (unknown)	25
20	Effects of mescaline dextro amphetamine and 2 hallucinogenic methoxy amphetamines on conditioned avoidance in rats 1976 ·(unknown), Hind T. Hatoum, Monique C. Braude	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact